These results confirm that abnormality in adenosine metabolism can contribute to retinal inflammation in diabetic retinopathy and suggest that the anti-inflammatory activity of A2A adenosine receptor signaling can be impaired in diabetic retinopathy due to increased ADA2 activity. Here, ADORA2A is linked to diabetic retinopathy.